Global - Impulse Dynamics
  • Home
  • Patients
  • Providers
    • CE Mark Indications & Patient Selection
    • Procedure and Mode of Action
    • Publications
    • Instructions for Use and Product Manuals
  • Company
    • News
    • Board of Directors
    • Executive Team
    • Governance
    • Resources
    • Careers
    • Contact Us
  • Events
  • Find A Doctor
  • REGION
    • US
    • DE
    • IT
    • Global
Select Page

The CFDA Approves Impulse Dynamics’ Optimizer System for Treatment of Chronic Heart Failure in China

by Impulse Dynamics | Dec 18, 2017 | Press Releases

NEWS The CFDA Approves Impulse Dynamics’ Optimizer System for Treatment of Chronic Heart Failure in China Orangeburg, New York & Stuttgart, Germany. December 18, 2017 – The China Food and Drug Administration (CFDA) has approved Impulse Dynamics’ Optimizer® system...

Recent Posts

  • Impulse Dynamics Receives Approval to Sell Optimizer CCM Devices in China
  • Global Regulatory Organization Certifies Optimizer Smart Device as Compliant for Whole-Body MRI Scans in the EU
  • Impulse Dynamics Announces FDA Approval for Magnetic Resonance Imaging
  • Impulse Dynamics Closes $60 Million Financing
  • Impulse Dynamics Announces First Heart Failure Patient Treated with CCM Therapy in Brazil

Recent Comments

  • 3twofold on The FIX-HF-16 clinical study to be supported by the Ludwigshafen research institute

Archives

  • February 2021
  • January 2021
  • April 2020
  • March 2020
  • December 2019
  • November 2019
  • October 2019
  • August 2019
  • March 2019
  • May 2018
  • December 2017
  • August 2017
  • May 2017
  • March 2017
  • September 2016
  • May 2016
  • March 2016
  • January 2016
  • November 2015
  • August 2015
  • July 2015
  • January 2015
  • December 2014

Categories

  • News and Events
  • Press Releases

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Like most websites on the internet, this website uses cookies. By using our website, you agree to our Cookie Policy. I Accept